ES433046A1 - Un procedimiento para preparar productos intermedios de prostaglandinas. - Google Patents

Un procedimiento para preparar productos intermedios de prostaglandinas.

Info

Publication number
ES433046A1
ES433046A1 ES433046A ES433046A ES433046A1 ES 433046 A1 ES433046 A1 ES 433046A1 ES 433046 A ES433046 A ES 433046A ES 433046 A ES433046 A ES 433046A ES 433046 A1 ES433046 A1 ES 433046A1
Authority
ES
Spain
Prior art keywords
formula
compound
represent
carbon atoms
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES433046A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES433046A1 publication Critical patent/ES433046A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
ES433046A 1972-11-08 1974-12-18 Un procedimiento para preparar productos intermedios de prostaglandinas. Expired ES433046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ES433046A1 true ES433046A1 (es) 1977-06-16

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
ES420325A Expired ES420325A1 (es) 1972-11-08 1973-11-07 Un procedimiento para preparar una prostaglandina.
ES433047A Expired ES433047A1 (es) 1972-11-08 1974-12-18 Un procedimiento para preparar productos intermedios de prostaglandinas.
ES433046A Expired ES433046A1 (es) 1972-11-08 1974-12-18 Un procedimiento para preparar productos intermedios de prostaglandinas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES420325A Expired ES420325A1 (es) 1972-11-08 1973-11-07 Un procedimiento para preparar una prostaglandina.
ES433047A Expired ES433047A1 (es) 1972-11-08 1974-12-18 Un procedimiento para preparar productos intermedios de prostaglandinas.

Country Status (29)

Country Link
JP (3) JPS5416491B2 (es)
AR (3) AR200585A1 (es)
AT (3) AT367034B (es)
AU (1) AU470375B2 (es)
BE (1) BE806995A (es)
CA (3) CA1085831A (es)
CH (1) CH597176A5 (es)
CS (3) CS182794B2 (es)
DD (4) DD118856A5 (es)
DE (1) DE2355540C2 (es)
DK (1) DK144247C (es)
ES (3) ES420325A1 (es)
FI (1) FI60389C (es)
FR (3) FR2205335B1 (es)
GB (3) GB1456514A (es)
HK (3) HK27979A (es)
HU (3) HU171819B (es)
IE (1) IE39537B1 (es)
IL (1) IL43589A (es)
IN (1) IN139384B (es)
KE (3) KE2930A (es)
MY (3) MY7900245A (es)
NL (1) NL164273C (es)
NO (3) NO147836C (es)
PH (3) PH13272A (es)
SE (4) SE448992B (es)
SU (4) SU584766A3 (es)
YU (3) YU39715B (es)
ZA (1) ZA738554B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
GB1506817A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
ES449162A1 (es) * 1975-06-23 1977-12-16 Syntex Inc Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (sv) * 1977-12-12 1979-06-13 Upjohn Co Anvendning av amider av prostaglandintyp for att styra eller reglera reproduktionscykeln hos individer tillhorande deggdjursarter
IN150279B (es) * 1978-01-16 1982-09-04 Pfizer
CA2303801C (en) * 1997-09-09 2005-05-10 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
JP2002329615A (ja) * 2001-05-02 2002-11-15 Ohira Denshi Kk トロイダルコイル
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US20060135609A1 (en) 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
SE431756B (sv) 1984-02-27
AT367034B (de) 1982-05-25
SU893130A3 (ru) 1981-12-23
SE448992B (sv) 1987-03-30
NO750535L (es) 1974-05-09
NO743493L (no) 1974-05-09
MY7900246A (en) 1979-12-31
NO148998C (no) 1984-01-25
SU667141A3 (ru) 1979-06-05
FI60389C (fi) 1982-01-11
SE7700717L (sv) 1977-01-24
DD109212A5 (es) 1974-10-20
MY7900245A (en) 1979-12-31
JPS5257147A (en) 1977-05-11
DE2355540C2 (de) 1982-11-18
AR199966A1 (es) 1974-10-08
FI60389B (fi) 1981-09-30
DD117233A5 (es) 1976-01-05
JPS5416491B2 (es) 1979-06-22
NO147836B (no) 1983-03-14
NO147836C (no) 1983-06-22
SE7700718L (sv) 1977-01-24
YU37316B (en) 1984-08-31
DK144247B (da) 1982-01-25
AT360672B (de) 1981-01-26
SE436278B (sv) 1984-11-26
ATA544576A (de) 1980-06-15
AU470375B2 (en) 1976-03-11
PH13325A (en) 1980-03-13
BE806995A (fr) 1974-05-07
ATA936973A (de) 1981-10-15
KE2931A (en) 1979-03-30
FR2283146B1 (es) 1981-06-19
IE39537L (en) 1974-05-08
FR2283146A1 (fr) 1976-03-26
JPS5253841A (en) 1977-04-30
DE2355540A1 (de) 1974-05-22
NO149139C (no) 1984-02-29
IE39537B1 (en) 1978-11-08
ES420325A1 (es) 1976-04-16
YU36975B (en) 1984-08-31
CS182791B2 (en) 1978-05-31
GB1456513A (en) 1976-11-24
SU745362A3 (ru) 1980-06-30
AR200585A1 (es) 1974-11-22
AT353285B (de) 1979-11-12
CA1088931A (en) 1980-11-04
GB1456514A (en) 1976-11-24
NO148998B (no) 1983-10-17
YU270680A (en) 1983-04-27
SE445111B (sv) 1986-06-02
GB1456512A (en) 1976-11-24
IN139384B (es) 1976-06-12
PH13272A (en) 1980-02-27
PH13110A (en) 1979-11-28
NO149139B (no) 1983-11-14
JPS4993342A (es) 1974-09-05
FR2205335A1 (es) 1974-05-31
NL164273C (nl) 1980-12-15
SE7700716L (sv) 1977-01-24
HK27979A (en) 1979-05-11
CH597176A5 (es) 1978-03-31
AU6224773A (en) 1975-05-08
CS182794B2 (en) 1978-05-31
KE2930A (en) 1979-03-30
DK144247C (da) 1982-07-12
CS182793B2 (en) 1978-05-31
KE2932A (en) 1979-03-30
MY7900243A (en) 1979-12-31
YU39715B (en) 1985-04-30
HU173507B (hu) 1979-05-28
IL43589A0 (en) 1974-03-14
HU171819B (hu) 1978-03-28
HK28079A (en) 1979-05-11
ES433047A1 (es) 1976-11-01
IL43589A (en) 1980-01-31
DE2365322A1 (de) 1974-11-07
HK28179A (en) 1979-05-11
YU270780A (en) 1982-06-18
CA1085831A (en) 1980-09-16
HU172703B (hu) 1978-11-28
FR2279729A1 (fr) 1976-02-20
DD118856A5 (es) 1976-03-20
NL7315263A (es) 1974-05-10
DE2365322B2 (de) 1977-02-24
FR2205335B1 (es) 1978-07-13
DD119411A5 (es) 1976-04-20
ATA544676A (de) 1979-04-15
FR2279729B1 (es) 1978-04-28
YU288073A (en) 1982-02-28
CA1088930A (en) 1980-11-04
AR202931A1 (es) 1975-07-31
SU584766A3 (ru) 1977-12-15
ZA738554B (en) 1974-09-25

Similar Documents

Publication Publication Date Title
ES433046A1 (es) Un procedimiento para preparar productos intermedios de prostaglandinas.
GB1266642A (es)
GB1515414A (en) 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins
ES420386A1 (es) Un procedimiento para preparar un pentanorprostaglandinas.
ES437039A1 (es) Procedimiento para preparar productos intermedios utiles en la preparacion de analogos de prostaglandinas.
GB1459564A (en) Alkylphenyl benzopyrans
GB1293312A (en) Phenyl derivatives and a process for the manufacture thereof
ES471349A1 (es) Un procedimiento para la preparacion de un compuesto de pi- rrolidona
ES434687A1 (es) Procedimiento para preparar productos intermedios tetrahi- dropiranilicos de prostaglandinas.
US4097519A (en) 2,2-Difluoro-16-phenoxy-PGA1 analogs
US4065631A (en) 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1β compounds
GB1421554A (en) Process for the stereoselective production of intermediates in the synthesis of pgea and derivatives
US4138574A (en) Cis-4,5-didehydro-16-phenoxy-PGA1 compounds
GB1508170A (en) Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues
ES462784A1 (es) Procedimiento para la produccion de cromanonas.
ES430416A1 (es) Procedimiento para preparar derivados de prostaglandina.
GB1446344A (en) Bis-tetrahydropyranyl-ethers
ES441002A1 (es) Un procedimiento para preparar oxaprostaglandinas.
GB1510053A (en) Aliphatic carbonyl compounds
US4212985A (en) cis-4,5-Didehydro-16-phenoxy-PGE1 compounds
GB1350326A (en) Distyrylbenzene derivatives
US4056554A (en) 2,2-Difluoro-16-phenoxy-13,14-dihydro-PGF1, analogs
ES8300321A1 (es) Un procedimiento para la preparacion de nuevas prostaglandi-nas
US4056557A (en) 2,2-Difluoro-16-phenoxy-PGF1 analogs
US4059614A (en) 2,2-Difluoro-16-phenoxy-PGE1 analogs